Wendy Chung

Director/Board Member at RALLYBIO CORPORATION

Net worth: 59 806 $ as of 2026-08-30

57 year

92 connections

Consumer Services

Commercial Services

Health Technology

Profile

Dr. Wendy K.
Chung is a Chairman-Department of Pediatric at The Children's Hospital Corp., an Independent Director at Rallybio Corp., an Independent Director at Prime Medicine, Inc., a Member at American College of Physicians, a Member at National Academy of Medicine and a Member at National Academy of Medicine (United States).
She is on the Board of Directors at Rallybio Corp.
and Prime Medicine, Inc. Dr. Chung was previously employed as a Professor by The Trustees of Columbia University in The City of New York.
She received her undergraduate degree from Cornell University, a doctorate degree from The Rockefeller University and a doctorate degree from Weill Cornell Medical College.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
RALLYBIO CORPORATION 0.07%	2026-09-15	3,562 ( 0.07% )	59 806 $	2026-08-30
PRIME MEDICINE, INC. -.--%	2026-06-04	0 ( -.--% )	- $	2026-08-30

Wendy Chung active positions

Companies	Position	Start
RALLYBIO CORPORATION	Director/Board Member	2022-07-31
PRIME MEDICINE, INC.	Director/Board Member	2021-10-31
National Academy of Medicine	Corporate Officer/Principal	-
National Academy of Medicine (United States) National Academy of Medicine (United States) Miscellaneous Commercial ServicesCommercial Services Operates as a professional membership organization	Corporate Officer/Principal	-
American College of Physicians American College of Physicians Miscellaneous Commercial ServicesCommercial Services Operates as a medical-specialty organization	Corporate Officer/Principal	-
The Children's Hospital Corp. The Children's Hospital Corp. Hospital/Nursing ManagementHealth Services Operates pediatric hospitals	Corporate Officer/Principal	2023-06-30

All active positions of Wendy Chung

Former positions of Wendy Chung

Companies	Position	End
The Trustees of Columbia University in The City of New York The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University	Corporate Officer/Principal	2023-06-30

See the detail of Wendy Chung's experience

Training of Wendy Chung

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Wendy Chung's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	10
The Trustees of Columbia University in The City of New York The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Cornell University Cornell University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
The Children's Hospital Corp. The Children's Hospital Corp. Hospital/Nursing ManagementHealth Services Operates pediatric hospitals	Health Services
The Rockefeller University The Rockefeller University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
National Academy of Medicine (United States) National Academy of Medicine (United States) Miscellaneous Commercial ServicesCommercial Services Operates as a professional membership organization	Commercial Services
Weill Cornell Medical College Weill Cornell Medical College Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
National Academy of Medicine
American College of Physicians American College of Physicians Miscellaneous Commercial ServicesCommercial Services Operates as a medical-specialty organization	Commercial Services
Prime Medicine, Inc. Prime Medicine, Inc. BiotechnologyHealth Technology Develops CRISPR gene editing technology	Health Technology
Rallybio Corp. Rallybio Corp. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that engages in research, development and commercialization of therapies for patients with severe & rare diseases	Health Technology